Amedeo Smart

Free Medical Literature Service

 

Amedeo

Breast Cancer
  Free Subscription

Articles published in
BMJ
    April 2024
  1. WISE J
    Breast cancer: Inaction on inequalities has led to unequal progress, say experts.
    BMJ. 2024;385:q854.
    >> Share

    February 2024
  2. FREEMAN K, Jenkinson D, Clements K, Wallis MG, et al
    Atypia detected during breast screening and subsequent development of cancer: observational analysis of the Sloane atypia prospective cohort in England.
    BMJ. 2024;384:e077039.
    >> Share

    January 2024
  3. MANNU GS, Wang Z, Dodwell D, Broggio J, et al
    Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort study.
    BMJ. 2024;384:e075498.
    >> Share

  4. SCHMIDT MK, Lips EH, Schmitz RS, Verschuur E, et al
    Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ.
    BMJ. 2024;384:q22.
    >> Share

  5. SARKAR S
    How patriarchy and conservatism fuel deadly hesitancy among women with breast cancer.
    BMJ. 2024;384:p2563.
    >> Share

    November 2023
  6. WEAVER N
    We must remove access barriers to endocrine drugs for breast cancer prevention.
    BMJ. 2023;383:p2709.
    >> Share


  7. Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial.
    BMJ. 2023;383:p2665.
    >> Share

  8. MAHASE E
    Anastrozole: Repurposed drug could prevent thousands of breast cancer cases.
    BMJ. 2023;383:p2608.
    >> Share

    October 2023
  9. MA F, Yan M, Li W, Ouyang Q, et al
    Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial.
    BMJ. 2023;383:e076065.
    >> Share

  10. SCHMITZ RSJM, van den Belt-Dusebout AW, Clements K, Ren Y, et al
    Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study.
    BMJ. 2023;383:e076022.
    >> Share

    September 2023
  11. DAVIES EA, Wang YH
    Understanding inequalities in breast cancer screening uptake.
    BMJ. 2023;382:p2084.
    >> Share

  12. HOFVIND S, Iqbal N, Thy JE, Mangerud G, et al
    Effect of invitation letter in language of origin on screening attendance: randomised controlled trial in BreastScreen Norway.
    BMJ. 2023;382:e075465.
    >> Share

  13. CATHCART-RAKE EJ, Tevaarwerk AJ, Haddad TC, D'Andre SD, et al
    Advances in the care of breast cancer survivors.
    BMJ. 2023;382:e071565.
    >> Share

  14. OKE JL, Welch HG
    Breast cancer: conflating case fatality with mortality.
    BMJ. 2023;382:p2086.
    >> Share

    August 2023
  15. MAHASE E
    Breast cancer screening: Overdiagnosis increases significantly with age, researchers say.
    BMJ. 2023;382:p1823.
    >> Share

    July 2023

  16. Breast cancer mortality in 500 000 women with early invasive breast cancer in England, 1993-2015: population based observational cohort study.
    BMJ. 2023;382:p1744.
    >> Share

    June 2023
  17. TAYLOR C, McGale P, Probert J, Broggio J, et al
    Breast cancer mortality in 500 000 women with early invasive breast cancer in England, 1993-2015: population based observational cohort study.
    BMJ. 2023;381:e074684.
    >> Share

  18. MACKENZIE M, Stobart H, Dodwell D, Taylor C, et al
    Risk of breast cancer death after a diagnosis of early invasive breast cancer.
    BMJ. 2023;381:p1355.
    >> Share

  19. KIRBY AM, Holt F, Taylor CW, Haviland JS, et al
    Should patients requiring radiotherapy for breast cancer be treated with proton beam therapy?
    BMJ. 2023;381:e072896.
    >> Share

    May 2023
  20. LEON-FERRE RA, Goetz MP
    Advances in systemic therapies for triple negative breast cancer.
    BMJ. 2023;381:e071674.
    >> Share

  21. TANNE JH
    Breast cancer: US recommends women start screening at 40.
    BMJ. 2023;381:1077.
    >> Share

  22. CLIFT AK, Dodwell D, Lord S, Petrou S, et al
    Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study.
    BMJ. 2023;381:e073800.
    >> Share

    April 2023
  23. GATHANI T, Cutress R, Horgan K, Kirwan C, et al
    Age and sex can predict cancer risk in people referred with breast symptoms.
    BMJ. 2023;381:e073269.
    >> Share

    March 2023
  24. FLEMING B, Edison P, Kenny L
    Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management.
    BMJ. 2023;380:e071726.
    >> Share

    February 2023
  25. BERDZULI N
    Breast cancer: from awareness to access.
    BMJ. 2023;380:290.
    >> Share

    January 2023
  26. LIMB M
    Black women in England are at greater risk of late cancer diagnosis than white women.
    BMJ. 2023;380:211.
    >> Share

    September 2022
  27. BUNDRED JR, Michael S, Stuart B, Cutress RI, et al
    Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis.
    BMJ. 2022;378:e070346.
    >> Share

  28. BUNDRED NJ, Bundred JR, Cutress RI, Dodwell D, et al
    Width of excision margins after breast conserving surgery for invasive breast cancer and distant recurrence and survival.
    BMJ. 2022;378:o2077.
    >> Share

    July 2022
  29. MENKES DB, Hoeh NR
    Doctor-patient relationship is essential to curtail overdiagnosis.
    BMJ. 2022;378:o1750.
    >> Share

  30. WISE J
    NICE approves two more treatment options for advanced breast cancer.
    BMJ. 2022;378:o1751.
    >> Share

    June 2022
  31. IACOBUCCI G
    NICE recommends new targeted treatment for early breast cancer.
    BMJ. 2022;377:o1491.
    >> Share

  32. PAPAUTSKY EL
    A full time job: a year with early-stage breast cancer.
    BMJ. 2022;377:o1421.
    >> Share

    May 2022
  33. WISE J
    NICE allows immunotherapy treatment for small group of patients with advanced triple negative breast cancer.
    BMJ. 2022;377:o1311.
    >> Share

  34. WISE J
    Breast cancer: NICE recommends innovative magnetic technology for locating sentinel lymph nodes.
    BMJ. 2022;377:o1226.
    >> Share

    March 2022
  35. SAUL H, Gursul D, Cassidy S, Vinogradova Y, et al
    Risk of breast cancer with HRT depends on therapy type and duration.
    BMJ. 2022;376:o485.
    >> Share

  36. TANNE JH
    Breast cancer is overdiagnosed in one in six or seven cases, finds large US study.
    BMJ. 2022;376:o581.
    >> Share

    January 2022
  37. BARTHOLOMEW T, Colleoni M, Schmidt H
    Financial incentives for breast cancer screening undermine informed choice.
    BMJ. 2022;376:e065726.
    >> Share

    December 2021
  38. CONFORTI F, Pala L, Sala I, Oriecuia C, et al
    Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis.
    BMJ. 2021;375:e066381.
    >> Share

  39. KRZYZANOWSKA MK, Julian JA, Gu CS, Powis M, et al
    Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial.
    BMJ. 2021;375:e066588.
    >> Share

    November 2021
  40. BRUCE J, Mazuquin B, Canaway A, Hossain A, et al
    Exercise versus usual care after non-reconstructive breast cancer surgery (UK PROSPER): multicentre randomised controlled trial and economic evaluation.
    BMJ. 2021;375:e066542.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016